| 1627 |
Dr. Jayant Goda |
Radiation Dose Optimization in Diffuse large B- cell Lymphoma - A Randomised Phase III non- inferiority trial. |
CTRI/2016/11/007485 |
Active accrual and intervention ongoing |
Radiation Oncology |
Adult Haemato Lymphoid |
| 1729 |
Dr. Hasmukh Jain |
A prospective observational study to determine the risk of Hepatitis B viral reactivation in adolescent and adult acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) with Occult Hepatitis B infection (OHBI). |
CTRI/2017/01/007747 |
Data Analysis ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 1755 |
Dr. Hasmukh Jain |
Role of IL-9 and Th9 cells in T cell lymphoma with cutaneous involvement |
CTRI/2017/04/008356 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 1979 |
Dr. Jayant Goda |
A dosimetric and clinical study of DIBH in Mediastinal Lymphomas: An exploratory observational study |
CTRI /2018/07/014847 |
Active accrual and intervention ongoing |
Radiation Oncology |
Adult Haemato Lymphoid |
| 3209 |
Dr. Manju Sengar |
Hematological Cancers Consortium: HCC Leukemia Registry |
CTRI/2020/02/023455 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3214 |
Dr. Hasmukh Jain |
A prospective observational cohort study to identify the utility of risk-based screening strategy for long term complications in adolescent and adult cancer survivors of leukemia and lymphoma. |
CTRI/2019/06/019880 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3257 |
Dr. Nehal Khanna |
A Prospective Randomized Phase III Trial of Short Course Versus Long Course Local Radiotherapy in patients with Multiple Myeloma symptomatic for Pain (ProM) |
CTRI/2020/01/022975\t |
Active accrual and intervention ongoing |
Radiation Oncology |
Adult Haemato Lymphoid |
| 3286 |
Dr. Tanuja Shet |
Classical Hodgkins lymphoma( CHL) with primary marrow presentation- does it use immune escape mechanism to hide ? |
|
Active enrollment ongoing |
Pathology |
Adult Haemato Lymphoid |
| 3353 |
Dr. Bhausaheb Bagal |
Protocol No. - 20160372 : Post-marketing Phase 4 Study to Evaluate Safety, Tolerability, and Efficacy of Kyprolis® (Carfilzomib) in Indian Patients With Relapsed or Refractory Multiple Myeloma: A Prospective, Open-label, Non-comparative, Multicenter Study |
CTRI/2019/06/019535 |
Data Analysis ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3380 |
Dr. Jayant Goda |
Total Marrow and Lymphoid Irradiation (TMLI) as conditioning regimen for peripheral stem cell transplant in high risk/ relapsed /refractory leukemias. |
CTRI/2019/11/022162 |
Active accrual and intervention ongoing |
Radiation Oncology |
Adult Haemato Lymphoid |
| 3423 |
Dr. Hasmukh Jain |
A phase II study to evaluate the role of short-course Pomalidomide in maintaining treatment-free remission post tyrosine-kinase inhibitor (TKI) discontinuation in adult patients with chronic myeloid leukemia-chronic phase (CML-CP). |
CTRI/2020/10/028549 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3465 |
Dr. Hasmukh Jain |
Phase I study to evaluate the feasibility and safety of addition of ruxolitinib to a standard BFM-90 regimen in adolescent/adult Ph-like ALL. |
CTRI/2021/02/031251 |
Active enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3466 |
Dr. Hasmukh Jain |
A study to validate the Multinational Association of Supportive Care in Cancer (MASCC) antiemesis tool for adolescent and adult patients with hematological malignancies receiving chemotherapy. |
CTRI/2020/10/028252 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3507 |
Dr. Manju Sengar |
A phase II randomized study to evaluate the efficacy of short-course RR CVEP regimen against short course EPOCH-RR in adolescent and adult seropositive Diffuse large B cell lymphoma |
CTRI/2020/10/028220 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3508 |
Dr. Hasmukh Jain |
A pilot study of indigenously manufactured HCAR19 (2nd generation Anti-CD19-41BBCD3 (zeta) chimeric antigen receptor T-cell therapy) in adult patients with relapsed/refractory diffuse large B-cell lymphoma. |
CTRI/2021/04/032727 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3552 |
Dr. Manju Sengar |
A phase II study to evaluate the activity of 177-Lu-DOTA Rituximab in adult patients with relapsed/refractory low-grade B-cell lymphomas. |
CTRI/2021/02/031578 |
Not started/Not initiated |
Medical Oncology |
Adult Haemato Lymphoid |
| 3586 |
Dr. Hasmukh Jain |
A study to develop an artificial intelligence algorithm for predicting the outcomes of febrile neutropenia (FN) in adolescent and adults with haematological malignancies. |
CTRI/2021/11/037855 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3620 |
Dr. Hasmukh Jain |
Evaluation of the safety and efficacy of generic low-dose Dasatinib for frontline therapy in chronic phase chronic myeloid leukemia - A multi-center phase II single arm study |
CTRI/2020/10/028317 |
Data Analysis ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3621 |
Dr. Hasmukh Jain |
A phase III randomized study to compare a risk-stratified and response adapted strategy to ABVD regimen in adolescents and adults with advanced-stage Hodgkin lymphoma. |
CTRI/2020/12/030132 |
Accrual completed and intervention ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3678 |
Dr. Manju Sengar |
Early T-cell precursor acute lymphoblastic leukaemia: Unravelling mechanisms of resistance and development of novel therapeutic strategies |
CTRI/2022/03/041157 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3722 |
Dr. Prashant Tembhare |
A retrospective analysis of flow cytometric immunophenotypic characterization and T-cell clonality determination in T cell non-Hodgkin's lymphoma. |
|
Accrual completed and follow-up ongoing |
Hemato-pathology |
Adult Haemato Lymphoid |
| 3754 |
Dr. Lingaraj Nayak |
An open label phase III randomized clinical trial of pomalidomide cyclophosphamide and dexamethasone versus pomalidomide dexamethasone in relapsed/ refractory multiple myeloma treated with lenalidomide and a proteasome Inhibitor. |
\tCTRI/2021/12/038872 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3851 |
Dr. Hasmukh Jain |
A single-arm phase II study(DASLOW) to evaluate the ability to maintain molecular response with Reduced dose Dasatinib(70 mg once daily) in patients with De-Novo Philadelphia positive Acute Lymphoblastic Leukemia (Ph+ ALL) after achieving deep molecular response during the intensive phase of treatment |
CTRI/2022/08/044923 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3856 |
Dr. Hasmukh Jain |
A prospective observational cohort study to evaluate the effectiveness and toxicities of standard regimen in elderly patients with De-Novo DLBCL. |
CTRI/2022/09/045751 |
Active Enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3871 |
Dr. Bhausaheb Bagal |
Protocol No. - ACE-LY-312(D8227C00001) : A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination with Rituximab, Cyclophosphamide,_x000D_\nDoxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects <= 75 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma |
CTRI/2022/03/041246 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 3936 |
Dr. Prashant Tembhare |
A retrospective study of the utility of new markers (CD148, CD180, CD200 and CD305) in the subtyping of mature B-cell non-Hodgkin lymphoma using flow cytometric immunophenotyping. |
|
Approved |
Hemato-pathology |
Adult Haemato Lymphoid |
| 3980 |
Dr. Tanuja Shet |
Burkitt-like lymphoma with 11q aberration - study on incidence and behaviour in Indian patients |
0 |
Active accrual and intervention ongoing |
Pathology |
Adult Haemato Lymphoid |
| 4009 |
Dr. Hasmukh Jain |
A phase II study of indigenously manufactured HCAR19 (2nd generation Anti-CD19-4-1BB-CD3ζ chimeric antigen receptor T-cell therapy) in adolescent and adult patients with relapsed/refractory B-cell malignancies. |
CTRI/2022/12/048211 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4026 |
Dr. Jayita Deodhar |
INTEGRATION OF SPECIALIST PALLIATIVE CARE IN HIGH-GRADE NON-HODGKIN'S LYMPHOMA PATIENTS (InSPeCt -HGNHL)- A Prospective observational study |
CTRI/2022/10/046652 |
Data Analysis ongoing |
Palliative Medicine |
Adult Haemato Lymphoid |
| 4034 |
Dr. Manju Sengar |
A Phase I study of maintenance therapy with combination of pomalidomide and oral azacytidine for adult patients with Acute Myeloid Leukaemia (AML). |
CTRI/2023/09/057552 |
Active accrual and intervention ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4075 |
Dr. Hasmukh Jain |
A novel Artificial Intelligence-based prognostic approach using PET-CT images and pathology images for advanced-stage Hodgkin Lymphoma |
CTRI/2024/02/062294 |
Data Analysis ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4120 |
Dr. Prashant Tembhare |
Role of immune surveillance in the persistence of minimal/measurable residual disease (MRD) and pathogenesis of relapse in adult B-cell acute lymphoblastic leukemia (B-ALL) |
|
Active Enrollment ongoing |
Hemato-pathology |
Adult Haemato Lymphoid |
| 4179 |
Dr. Manju Sengar |
A single centre prospective observational study to compare the outcomes and toxicities of Azacitidine + Venetoclax (AZA + VEN) with 3+7 induction chemotherapy (IC) with Cytarabine and Daunorubicin in patients with Acute Myeloid Leukemia (AML)_x000D_\n_x000D_\n |
CTRI/2023/06/053981 |
Active enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4223 |
Dr. Tanuja Shet |
Incidence and prognostic value of EZH2 mutations in follicular lymphoma |
|
Case review/sample review ongoing (audit studies) |
Pathology |
Adult Haemato Lymphoid |
| 4227 |
Dr. Manju Sengar |
Assessment of patient perceptions, resource utilisation and utility of tramadol as pre procedural analgesia in bone marrow aspiration and biopsy. |
CTRI/2024/01/062117. |
Active enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4262 |
Dr. Akshay Baheti |
ROLE OF ARTIFICIAL INTELLIGENCE IN EVALUATION OF NCCT THORAX IN PATIENTS WITH FEBRILE NEUTROPENIA |
|
Data Analysis ongoing |
Radio-diagnosis |
Adult Haemato Lymphoid |
| 4265 |
Dr. Sneha Shah |
BASELINE METABOLIC FDG PET/CT PARAMETERS AS A PROGNOSTICATON MARKER IN ADULT DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). |
|
Data Analysis ongoing |
Nuclear Medicine |
Adult Haemato Lymphoid |
| 4277 |
Dr. Shamali Poojary |
MORPHINE MOUTHWASH VERSUS KETAMINE MOUTHWASH FOR ACUTE PAIN IN PATIENTS OF HEMATOLYMPHOID CANCERS WITH CHEMOTHERAPY INDUCED ORAL MUCOSITIS - A RANDOMISED CONTROLLED STUDY _x000D_\n_x000D_\n |
CTRI/2024/01/062050 |
Active accrual and intervention ongoing |
Palliative Medicine |
Adult Haemato Lymphoid |
| 4324 |
Dr. Lingaraj Nayak |
Protocol No. - CA057008 : A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480 (BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM) |
CTRI/2023/08/056910 |
Active enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4351 |
Dr. Uma Sakhdeo |
A study of clinico-pathological parameters and PDL1 expression in Diffuse large B cell lymphoma involving the testis. |
|
Case review/sample review ongoing (audit studies) |
Pathology |
Adult Haemato Lymphoid |
| 4403 |
Dr. Hasmukh Jain |
Risk-adapted PET-CT-guided Therapy for Adults with Newly Diagnosed Classical Hodgkin Lymphoma using ABVD and EACODD-14 Regimens (HL-Russia-1). |
NCT04638790 |
Not started/Not initiated |
Medical Oncology |
Adult Haemato Lymphoid |
| 4478 |
Dr. Bhausaheb Bagal |
A Phase 1, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 2001 in Subjects with Relapsed/Refractory Multiple Myeloma |
|
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4480 |
Dr. Alok Shetty |
Enhancing health record digitization using AI-powered ambient clinical intelligence solutions - a pilot study |
CTRI/2024/11/076365 |
Active enrollment ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4513 |
Dr. Manju Sengar |
Phase III open labelled randomized controlled study to evaluate the optimal dose of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. |
CTRI/2023/09/057990 |
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4520 |
Dr. Manju Sengar |
Phase I/II study of BCMA directed humanised CAR-T cell therapy (hBCMA) in patients with relapsed/refractory Multiple myeloma. |
CTRI/2025/01/079364 |
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4532 |
Dr. Hasmukh Jain |
A Phase III RCT comparing AVD+ low dose nivolumab versus ABVD using a risk-adapted strategy in newly diagnosed advanced stage classical Hodgkin lymphoma. |
CTRI/2024/03/063942 |
Ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4551 |
Dr. Hasmukh Jain |
A multicentre Phase III randomized control trial to test the efficacy of targeted agents during induction and a response-adapted consolidation in adolescent and young adult patients with de-novo ALL_x000D_\n |
CTRI/2025/03/082015 |
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4602 |
Dr. Manju Sengar |
Deploying Oncology Specific Telemedicine (TeleOPD) platform in the North- Eastern states of India- a pilot study_x000D_\n_x000D_\n |
CTRI/2025/02/080742 |
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4644 |
Dr. Manju Sengar |
Integration of machine learning and genomics to predict outcomes for newly diagnosed,_x000D_\nrelapsed and refractory mature T-cell and NK-cell neoplasms. |
|
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4685 |
Dr. Hasmukh Jain |
Phase II study of immunotherapy in combination with CAR T-cell therapy (ACTALY CEL) in adults, adolescents patients with relapsed/refractory DLBCL |
CTRI/2025/03/082608 |
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4689 |
Dr. Amrita Guha |
IMAGING ANALYSIS OF PATTERNS OF RESPONSE ASSESSMENT IN PRIMARY CNS LYMPHOMA |
|
Approved |
Radio-diagnosis |
Adult Haemato Lymphoid |
| 4701 |
Dr. Bhausaheb Bagal |
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Chemotherapy vs Placebo Plus R-CHOP Chemotherapy in Participants with Previously Untreated High-risk Large B-cell Lymphoma |
|
Ongoing |
Medical Oncology |
Adult Haemato Lymphoid |
| 4718 |
Mrs. Anita D Souza |
A feasibility study of mindfulness meditation and fatigue in patients planned to receive chemotherapy for non-Hodgkin lymphoma in Tata Memorial Hospital Mumbai. |
CTRI/2025/06/088478 |
Approved |
Nursing Services |
Adult Haemato Lymphoid |
| 4720 |
Dr. Jayita Deodhar |
INTEGRATION OF SPECIALIST PALLIATIVE CARE IN RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES UNDERGOING CAR-T CELL THERAPY: A PILOT SINGLE-ARM SINGLE-CENTER PROSPECTIVE OBSERVATIONAL STUDY_x000D_\n_x000D_\n |
CTRI/2025/05/086476 |
Approved |
Palliative Medicine |
Adult Haemato Lymphoid |
| 4729 |
Dr. Hasmukh Jain |
A Phase 1, Open Label, Dose Escalation, Multicenter, First-in-Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR112 in Patients with Relapsed Advanced Lymphoma (ADITI-1) |
|
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4739 |
Dr. Uma Sakhdeo |
EBV expression in Diffuse large B cell lymphoma-nodal and extranodal |
|
Approved |
Pathology |
Adult Haemato Lymphoid |
| 4753 |
Dr. Kunal Gala |
Retrospective analysis of diagnostic accuracy and safety of image guided spleen biopsy. |
|
Approved |
Radio-diagnosis |
Adult Haemato Lymphoid |
| 4759 |
Dr. Bhausaheb Bagal |
An Open Label, Multicenter, Phase IV Study of Teclistamab to Evaluate its Safety in Indian Participants with Relapsed and Refractory Multiple Myeloma who have previously received at least 3 prior lines of therapy including an Immunomodulatory agent, a Proteasome Inhibitor and an Anti-CD38 antibody and have demonstrated disease progression on the last therapy. |
CTRI/2025/05/086109 |
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4926 |
Dr. Manju Sengar |
Novel and optimized de-intensified induction therapy in acute myeloid leukemia |
|
Approved |
Medical Oncology |
Adult Haemato Lymphoid |
| 4952 |
Dr. Gaurav Salunke |
Evaluate the performance of plasma based metagenomic sequencing in detecting pathogens causing sepsis in Hematological cancer patients |
|
Approved |
Microbiology |
Adult Haemato Lymphoid |